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M
acromolecular diffusion is
essential to cell function
but largely restricted by the
viscosity of the cytosol and
the dense meshwork of cytoskeletal fila-
ments. The actin and microtubule cy-
toskeleton together with associated
motors are responsible for macromolec-
ular transport in the cytoplasm, but we
still lack major insights into the nature
and regulation of cargo binding to mo-
tors. Research on virus nanoparticles
has provided cues to the regulation of
cytoplasmic transport. To commandeer
its host, a virus must elude host restric-
tions at multiple levels, including entry,
cytoplasmic transport, replication, innate
and adaptive immune recognition, and
egress from the infected cell. Viruses
that replicate their genomes in the nu-
cleus use microtubule motors for traf-
ficking toward the nuclear membrane
during entry and the periphery during
egress after replication. How viruses
achieve different transport directionali-
ties in the same cell has been a long-
standing puzzle to cell biologists and
virologists.
In their work, published in this issue
of PNAS, Luxton et al. (1) use an
-herpesvirus, pseudorabies virus
(PRV), to provide evidence that the
composition of intracellular viruses is
associated with the directional f low of
the particles in axons of dorsal root gan-
glia neurons. PRV is a neurotropic her-
pesvirus whose natural hosts are pigs,
and the virus is related to human herpes
simplex virus (HSV). It has an icosahe-
dral capsid, a surrounding tegument of
many different proteins, and a limiting
lipid envelope with glycoproteins. Like
HSV, PRV infects mucosal epithelia and
enters nerve termini, from where it traf-
fics to and delivers its genome into the
nucleus of the cell body. In the nucleus,
the genome may give rise to infectious
progeny or become latent with little
gene expression. The silenced genome
can be reactivated upon stress and es-
tablish a productive infection in the pe-
ripheral nervous system and, later, also
in the mucosal periphery, where newly
synthesized particles infect other individ-
uals. This lifestyle is notable in its com-
plexity, and it is very successful, docu-
mented by the fact that -herpesviruses
are found in essentially all vertebrates (2).
To get at the heart of how herpesvirus
masters its trafficking, a thorough analysis
of the capsid composition during entry
and egress is required. Viral uncoating in
entry is irreversible and tightly controlled
(3). This finding, together with genetic
and cell biological examinations of HSV
and PRV have set the stage for the work
by Luxton et al. (1). HSV and PRV typi-
cally fuse their envelope with the plasma
membrane and release a capsid and acces-
sory factors of the tegument into the cy-
tosol. Although many of the tegument
proteins have regulatory functions and are
transported independently into the nu-
cleus, the capsid with the viral DNA and
certain tegument proteins traffic on mi-
crotubules toward the nucleus. In epithe-
lial cells, this locomotion is mediated by
the dyneindynactin motor complex (4).
Hours later, newly synthesized capsids
leave the nucleus with the help of tegu-
ment proteins and host factors. Capsids
then travel to Golgi membranes for envel-
opment and direction to the plasma mem-
brane, as indicated by studies in epithelial
cells. The events in neuronal cells are
less clear. A significant step forward has
been the generation of viable herpes-
viruses carrying GFP insertions, e.g., the
GFP-tagged outer HSV capsid protein
VP26 (5) or the HSV accessory proteins
of the outer tegument, UL47(VP1314)
(6), UL48(VP16) (7), and UL49(VP22)
(8). The use of GFP-tagged proteins has
led to the observation that herpesviruses
are trafficked bidirectionally on unipolar
axonal microtubules by using dynein in
entry and a kinesin motor in exit (9),
much like adenoviruses and influenza
viruses.
What are the benefits of the wide-
spread bidirectional transport? The most
important advantage is that the cargo
can roam through the cytoplasm and
establish a uniform distribution in any
subcellular region. This transport mode
avoids potential sinks, for example, the
microtubule-organizing center clustering
the minus ends of the microtubules. Bi-
directional transport also enables a
cargo to detach from the motors or de-
tach the motor from the track without
necessarily loosing contact with the
See companion article on page 5832.
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Fig. 1. Three principal viral strategies to regulate microtubule-dependent viral transport. (A) Kinase-
mediated unloading of the poxvirus, vaccinia virus, from kinesin. Newly synthesized virus travels on
microtubules toward the periphery by using kinesin bound to the outer membrane protein A36R (step 1),
fuses with the plasma membrane, and activates the cellular Src tyrosine kinase, which phosphorylates
A36R and detaches kinesin (step 2), triggering actin polymerization underneath the extracellular virus
(step 3). (B) Kinase-regulated transport of adenovirus. Coxsackie virus B adenovirus receptor (CAR) and
integrin coreceptors engaged with virus activate PKA (step 1), and an unknown trigger activates p38
MAPK (step 2), which boosts dyneindynactin-mediated minus end-directed transport and inhibits plus
end-directed transport of cytosolic viruses (step 3). (C) Molecular composition of cargo correlates with
transport preference. Herpesvirus capsids free of outer tegument proteins are delivered to the cytosol
(step 1) and recruit the dyneindynactin motor by inner tegument or outer capsid proteins for nuclear
transport (step 2) and replication (step 3). Newly synthesized capsids acquire inner and outer tegument
proteins, allowing viral transport to the nerve termini (step 4).











track; it allows the cargo to define a
transport preference depending on its
functional state, for example, incoming
capsids moving to the minus ends and
newly synthesized capsids to the plus
ends. The work by Luxton et al. (1) pro-
vides evidence for the possibility that
motors are differentially recruited to
PRV capsids, depending on the capsid
composition, or that they stay on the
cargo but are regulated, i.e., silenced or
activated. By using dual color video mi-
croscopy of PRV capsids tagged with
monomeric red fluorescent protein
(mRFP)-VP26 and five different GFP-
tagged PRV tegument proteins in ex-
planted dorsal root ganglion neurons,
these authors (1) show that the incom-
ing capsids release the UL47, UL48,
and UL49 tegument proteins before
they traffic to the nucleus, consistent
with recent immuno-EM analyses of
PRV entry (10). Both studies found
that the inner tegument proteins
UL36(VP12) and UL37 remained asso-
ciated with incoming capsids. These
inner proteins are conserved among -,
-, and -herpesviruses and have impor-
tant roles in virion morphogenesis (11).
The inner proteins are most likely not
subject to regulation for capsid traffick-
ing but are good candidate receptors for
dyneindynactin.
How could capsid transport be regu-
lated? One possibility is that protein
phosphorylation by viral or cellular
kinases modulates the tegument com-
position. An intriguing example of
kinase-regulated viral transport is vac-
cinia virus (12). Newly synthesized
intracellular enveloped viruses are
transported to the plasma membrane
on microtubules upon binding of the
outer membrane protein A36R to con-
ventional kinesin and fuse with the
plasma membrane (Fig. 1). The infec-
tious virus remains tethered to the
plasma membrane until a second viral
protein activates an unknown host re-
ceptor to trigger the cellular tyrosine
kinase Src. Src phosphorylates plasma
membrane-associated A36R and un-
loads it from kinesin-activating actin
polymerization underneath the extra-
cellular virus to launch virus away
from the infected cell and spread viral
progeny. Another example of kinase-
regulated microtubule-dependent trans-
port is adenovirus. The major motor
transporting adenovirus to the nucleus
of epithelial cells is dyneindynactin
(13). Adenovirus entry activates protein
kinase A (PKA) and the p38mitogen-
activated protein kinase (MAPK) path-
way (14, 15). PKA and p38 increase the
number and velocity of dynein-mediated
motility steps, consistent with the notion
that these pathways either inhibit kine-
sin motility or boost dynein motility
(Fig. 1). In the absence of these activa-
tions, cytosolic viruses are transported
to the microtubule plus ends in the pe-
riphery. In addition, the composition of
the capsid is critical for the directional-
ity of transport as intact capsids are
shuffled out in activated cells, emphasiz-
ing the importance of local regulation.
Likewise, herpesvirus transport may be
regulated locally, because viral entry
does not disturb ongoing cellular trans-
port and is not affected by viruses in
egress (16). The acquisition of the outer
tegument proteins UL47, UL48, and
UL49 coincides with plus end-directed
traffic of the capsids (Fig. 1) (1). The
question is whether any of these pro-
teins are kinesin receptors. Although
UL47 is unlikely a kinesin receptor be-
cause it is absent on incoming capsids
moving bidirectionally, the US11 tegu-
ment protein of HSV is involved in reg-
ulated plus end-directed capsid trans-
port. This protein binds to the heavy
chain of conventional kinesin by its C
terminus, which also binds a variety of
other proteins subject to regulation (17).
The herpesvirus case is even more in-
triguing because a recent study reported
an amazing heterogeneity of individual
PRV virions and PRV capsids in axons
with respect to the UL49(VP22) protein
(18). This heterogeneity was revealed by
observing individual capsids by fluores-
cence microscopy. It might help resolving
decade-long discussions on how herpesvi-
rus capsids are shuttled to the cell sur-
face, i.e., through the secretory pathway
or the cytosol. A current model suggests
that capsids are recruited to the mobile
fraction of tegument on membranes or
free in the cytosol for outward piggy-
back shuttling by a plus end-directed
motor, whereas other capsids would
move independently of viral glycopro-
teins. This hypothesis is supported by
the observation that UL47 and UL49
but not UL48 clusters move with and
without associated capsids (1). It is pos-
sible that the outward moving capsids
retain the dyneindynactin receptor, im-
plying a silencing or detachment mecha-
nism of dynein. If subviral complexes
rather than intact virions were the pre-
ferred transport cargoes, it could help
ensure that exit-competent virus parti-
cles are formed preferably at sites of
cell–cell contact, the predominant loca-
tions of viral transmission to noninfected
cells. In other instances, a secretory mech-
anism of intact virions may be used.
In any case, the experimental systems
presented by the recent studies of PRV
(1, 18) are remarkable because they
reproduce a key aspect of herpesvirus
pathology, axonal transport over long
distances, and combine it with func-
tional analyses of viable blazing viruses.
Further technical improvements to in-
crease the sensitivity, spatial and tempo-
ral imaging resolutions, and automated
tracking of viral f luorescent point
sources are on the horizon. We can look
forward to learn more about the intrica-
cies of how viruses violate the trafficking
regulations of their hosts. Uncovering
these tricks might eventually be of medi-
cal benefit to deliver subcellular thera-
peutics with nanoprecision.
I thank C. Burckhardt, C. Fraefel, and S.
Strunze (University of Zu¨rich); B. Sodeik
(Medical School of Hannover, Hannover,
Germany); and T. Mettenleiter (Friedrich-
Loeffler-Institut, Insel Riems, Germany)
for comments on the text. This work was
supported by the Swiss National Science
Foundation.
1. Luxton, G. W. G., Haverlock, S., Coller, K. E.,
Antinone, S. E., Pincetic, A. & Smith, G. A. (2005)
Proc. Natl. Acad. Sci. USA 102, 5832–5837.
2. Davison, A. J. (2002) Vet. Microbiol. 86, 69–88.
3. Greber, U. F. & Fassati, A. (2003) Traffic 4,
136–143.
4. Dohner, K., Wolfstein, A., Prank, U., Echeverri,
C., Dujardin, D., Vallee, R. & Sodeik, B. (2002)
Mol. Biol. Cell 13, 2795–2809.
5. Desai, P. & Person, S. (1998) J. Virol. 72, 7563–
7568.
6. Donnelly, M. & Elliott, G. (2001) J. Virol. 75,
2575–2583.
7. Bearer, E. L., Breakefield, X. O., Schuback, D.,
Reese, T. S. & LaVail, J. H. (2000) Proc. Natl.
Acad. Sci. USA 97, 8146–8150.
8. Elliott, G. & O’Hare, P. (1999) J. Virol. 73, 4110–
4119.
9. Smith, G. A. & Enquist, L. W. (2002) Annu. Rev.
Cell Dev. Biol. 18, 135–161.
10. Granzow, H., Klupp, B. G. & Mettenleiter, T. C.
(2005) J. Virol. 79, 3200–3205.
11. Mettenleiter, T. C. (2004) Virus Res. 106, 167–
180.
12. Newsome, T. P., Scaplehorn, N. &Way, M. (2004)
Science 306, 124–129.
13. Sodeik, B. (2000) Trends Microbiol. 8, 465–472.
14. Suomalainen, M., Nakano, M. Y., Boucke, K.,
Keller, S., Stidwill, R. P. & Greber, U. F. (1999)
J. Cell Biol. 144, 657–672.
15. Suomalainen, M., Nakano, M. Y., Boucke, K.,
Keller, S. & Greber, U. F. (2001) EMBO J. 20,
1310–1319.
16. Smith, G. A., Pomeranz, L., Gross, S. P. & En-
quist, L. W. (2004) Proc. Natl. Acad. Sci. USA 101,
16034–16039.
17. Diefenbach, R. J., Miranda-Saksena, M., Diefen-
bach, E., Holland, D. J., Boadle, R. A., Armati,
P. J. & Cunningham, A. L. (2002) J. Virol. 76,
3282–3291.
18. del Rio, T., Ch’ng, T., Gross, S. & Enquist, L.
(2005) J. Virol. 79, 3903–3919.
5640  www.pnas.orgcgidoi10.1073pnas.0501696102 Greber
